Tags : DIALIZE Study

AstraZeneca Reports Results of Lokelma (sodium zirconium cyclosilicate) in P-IIIb

Tuba Khan June 14, 2019

Shots: The P-IIIb DIALIZE study results involve assessing of Lokelma vs PBO in n 196 patients on hemodialysis with hyperkalemia in ESRD The P-IIIb DIALIZE study resulted in maintaining normal […]readmore

Tags : DIALIZE Study

AstraZeneca Reports Results of Lokelma (sodium zirconium cyclosilicate) in P-IIIb

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : DIALIZE Study

﻿AstraZeneca Reports Results of Lokelma (sodium zirconium cyclosilicate) in P-IIIb

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company

AstraZeneca Reports Results of Lokelma (sodium zirconium cyclosilicate) in P-IIIb